Rehovot, Israel

Aric Orbach

This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Prilenia Neurotherapeutics Ltd.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aric Orbach. Retrieved from https://idiyas.com/inventor/aric-orbach

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0


 

Average Co-Inventor Count = 3.3

ph-index = 1


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Aric Orbach in Neurotherapeutics

Introduction

Aric Orbach is a notable inventor based in Rehovot, Israel, recognized for his significant contributions to the field of neurotherapeutics. With a total of three patents to his name, he focuses on developing innovative methods to address drug-induced movement disorders and neurodegenerative eye diseases.

Latest Patents

Among his latest inventions are two groundbreaking patents. The first is for **Pridopidine for treating drug-induced dyskinesias**, which outlines a method for periodically administering pridopidine or its pharmaceutically acceptable salts to treat subjects suffering from drug-induced movement disorders, including levodopa-induced dyskinesia. This invention also provides a preventive approach for those at risk of developing such disorders. The second patent, **Treatment of neurodegenerative eye disease using pridopidine**, presents a method for administering pridopidine to individuals afflicted with neurodegenerative eye diseases, establishing a new avenue for therapeutic intervention.

Career Highlights

Aric Orbach has made considerable strides at Prilenia Neurotherapeutics Ltd., where he works alongside a talented team dedicated to advancing scientific research and patient care. His innovative work stands out in the realm of neurotherapeutics, particularly concerning the treatment of complex conditions associated with neurodegeneration and medication side effects.

Collaborations

Orbach has collaborated with esteemed colleagues, including Michal Geva and Michael Hayden. Together, they contribute to cutting-edge research efforts at their company, focusing on creating impactful solutions for patients experiencing challenging neurological conditions.

Conclusion

Aric Orbach's work exemplifies the power of innovation in addressing significant medical challenges. With his latest patents pushing the boundaries of neurotherapeutics, he continues to play an essential role in the quest for effective treatments and improved patient outcomes. His commitment to developing novel approaches solidifies his status as an influential inventor in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…